Relationship between tumor-associated immune infiltrate and p16 staining over clinicopathological features in acral lentiginous melanoma
Carlos A. Castañeda(Instituto Nacional de Enfermedades Neoplásicas), Julio E. Abugattas(City of Hope), Jorge Dunstan(The University of Texas MD Anderson Cancer Center), Luis A. Bernabe(Instituto Nacional de Enfermedades Neoplásicas), José M. Cotrina(Instituto Nacional de Enfermedades Neoplásicas), Brayam Felix(Instituto Nacional de Enfermedades Neoplásicas), Carlos A. Torres‐Cabala(The University of Texas MD Anderson Cancer Center), Miluska Castillo(Instituto Nacional de Enfermedades Neoplásicas), Henry Gómez(National Cancer Center), Valeria Villegas(Universidad Peruana Cayetano Heredia), Sandro Casavilca‐Zambrano(Institute for Anthropological Research), Maria P Landa-Baella(Instituto Nacional de Enfermedades Neoplásicas), Carlos Chávez(Instituto Nacional de Enfermedades Neoplásicas), Katherine Tello(Instituto Nacional de Enfermedades Neoplásicas), Miguel De la Cruz(The University of Texas MD Anderson Cancer Center), Joselyn Sanchez(Instituto Nacional de Enfermedades Neoplásicas)
Cited by 28
Related Papers
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
|New England Journal of Medicine|2018|684
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
|The Lancet|2009|665
Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment
|Journal of Clinical Oncology|2007|483